Stockscreener 앱 받기
22.88
2.10%
-0.49
시장 영업 전:
22.58
-0.30
-1.31%
Newamsterdam Pharma Company Nv (NAMS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 |
| 기간 | 3개월 |
| Revenues | |
Operating Expenses
|
|
| Benefits Costs and Expenses | |
| Costs And Expenses | |
| Operating Income/Loss | |
| Income/Loss From Continuing Operations Before Tax | |
| Income/Loss From Continuing Operations After Tax | |
|
Net Income/Loss
|
|
| Preferred Stock Dividends And Other Adjustments | |
| Attributable To Noncontrolling Interest | |
| Basic Average Shares | |
| Diluted Average Shares | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
2.14%
2.83%
자본화:
|
볼륨(24시간):